Latest News

Chinese Cardiologists Visit UNC Medical Center as Part of AHA Collaboration

Chinese Cardiologists Visit UNC Medical Center as Part of AHA Collaboration

A delegation of medical professionals from across China toured Chapel Hill’s emergency department, cardiac catheterization lab and other facilities to learn about UNC’s STEMI system of care.

Chinese Cardiologists Visit UNC Medical Center as Part of AHA Collaboration - Read More…

Roper and Burriss named to '183 nonprofit hospital and health system CEOs to know 2017'

Roper and Burriss named to '183 nonprofit hospital and health system CEOs to know 2017'

According to Becker's Hospital Review, "The men and women on this list lead some of the largest and most successful nonprofit healthcare organizations in the country. "

Roper and Burriss named to '183 nonprofit hospital and health system CEOs to know 2017' - Read More…

An Obsession to Serve

An Obsession to Serve

After 10 years as a US Army medic, Rick Cowan turned to the UNC School of Medicine, where he will graduate this year as a physician assistant.

An Obsession to Serve - Read More…

UNC Scientists Discover Proteins Keeping Stem Cells in their Undifferentiated State

UNC Scientists Discover Proteins Keeping Stem Cells in their Undifferentiated State

The lab of Jean Cook, PhD, found how a chain of proteins called an MCM complex could enable the fast cell-division that makes some forms of cancer so dangerous.

UNC Scientists Discover Proteins Keeping Stem Cells in their Undifferentiated State - Read More…

Immunotherapy Could Be Beneficial for Relapsed Acute Myeloid Leukemia

Immunotherapy Could Be Beneficial for Relapsed Acute Myeloid Leukemia

Researchers led by UNC Lineberger's Joshua Zeidner, MD, presented preliminary results from an ongoing phase II trial of the checkpoint inhibitor pembrolizumab and chemotherapy for relaposed or refractory acute myeloid leukemia at the 59th American Society of Hematology Annual Meeting in Atlanta.

Immunotherapy Could Be Beneficial for Relapsed Acute Myeloid Leukemia - Read More…

Biological Factors Don't Completely Explain Racial Disparities for ‘Good Prognosis’ Breast Cancer

Biological Factors Don't Completely Explain Racial Disparities for ‘Good Prognosis’ Breast Cancer

The biological features of patients’ tumors partially explained a racial disparity for women with hormone receptor-positive, HER2-negative breast cancer, but UNC Lineberger researchers led by Katherine Reeder-Hayes, MD, MBA, MSc, said it didn’t explain it completely. The preliminary findings were reported at the 2017 San Antonio Breast Cancer Symposium.

Biological Factors Don't Completely Explain Racial Disparities for ‘Good Prognosis’ Breast Cancer - Read More…

Using Software, Researchers Predict Tumor Markers That Could Be Immune Targets

Using Software, Researchers Predict Tumor Markers That Could Be Immune Targets

UNC Lineberger researchers led by Benjamin Vincent, MD, reported preliminary findings at the 59th ASH Annual Meeting in Atlanta that are an early step in the overall plan to use the software’s predictions to develop immune-based therapies for leukemia.

Using Software, Researchers Predict Tumor Markers That Could Be Immune Targets - Read More…

NCI Grant to Help More Cancer Patients Become Tobacco-Free

NCI Grant to Help More Cancer Patients Become Tobacco-Free

A grant from the National Cancer Institute will help expand tobacco cessation programs for cancer patients at the N.C. Cancer Hospital. Adam O. Goldstein, MD, MPH, will lead the effort.

NCI Grant to Help More Cancer Patients Become Tobacco-Free - Read More…

Department of Pharmacy Earns $50,000 Award for Excellence in Medication Safety

Department of Pharmacy Earns $50,000 Award for Excellence in Medication Safety

The American Society of Hospital Pharmacists Foundation and the Cardinal Health Foundation honored a team of UNC pharmacist for their successful efforts to address rare and serious complications resulting from blood thinners.

Department of Pharmacy Earns $50,000 Award for Excellence in Medication Safety - Read More…

National Clinical Trial Finds Certain Treatments for Blood Clots Not Effective

National Clinical Trial Finds Certain Treatments for Blood Clots Not Effective

Stephan Moll, MD, professor of medicine and member of the UNC Hemophilia and Thrombosis Center, co-authored the results of a large-scale multicenter clinical trial focusing on catheter-directed thrombolysis and its effects.

National Clinical Trial Finds Certain Treatments for Blood Clots Not Effective - Read More…

Addressing the burden of glaucoma in Ghana

Addressing the burden of glaucoma in Ghana

Rates of glaucoma in Ghana are the second highest in the world. For more than 20 years, Don Budenz, Chair of the Department of Ophthalmology, has traveled to the West African nation to treat patients, train providers, and raise public awareness of the condition.

Addressing the burden of glaucoma in Ghana - Read More…

Scientists Find Potential Weapons for the Battle Against Antibiotic Resistance

Scientists Find Potential Weapons for the Battle Against Antibiotic Resistance

Led by UNC School of Medicine’s Brian Conlon, PhD, research published in PLoS Biology shows how different bacterial strains interact to make each other more or less resistant to antibiotics.

Scientists Find Potential Weapons for the Battle Against Antibiotic Resistance - Read More…

The Hunt for a Cure to HIV

The Hunt for a Cure to HIV

In recognition of World AIDS Day on Dec. 1, UNC Health Care and our friends at StoryDrivenMedia created this video featuring HIV Cure Center researchers David Margolis, MD, and Nancie Archin, PhD, as well as clinical trial participant Rob Hill.

The Hunt for a Cure to HIV - Read More…

NIH renews grant funding the Bowles Alcohol Research Center

NIH renews grant funding the Bowles Alcohol Research Center

The center, established 20 years ago and led by Fulton Crews, PhD, will receive more than $8.7 million over five years to continue research on the effects of alcohol on the brain.

NIH renews grant funding the Bowles Alcohol Research Center - Read More…

Inaugural Class of UNC Physician Assistant Program Featured by Blue Cross and Blue Shield of NC

Inaugural Class of UNC Physician Assistant Program Featured by Blue Cross and Blue Shield of NC

An article published on the BCBS website focuses on one upcoming graduate’s experience in the program, her motivation for pursuing a career as a physician assistant, and her goals after graduating this December.

Inaugural Class of UNC Physician Assistant Program Featured by Blue Cross and Blue Shield of NC - Read More…

Celebrating Student Research

The 50th annual Student Research Day was held on Nov. 17. Medical Students had the opportunity to showcase their summer research work.

Celebrating Student Research - Read More…

Pairing cancer genomics with cognitive computing highlights potential therapeutic options

Pairing cancer genomics with cognitive computing highlights potential therapeutic options

Study findings suggest that cognitive computing could help physicians to stay abreast of an ever-expanding body of scientific literature as well as highlight potential cancer therapeutic options. UNC Lineberger's William Kim, MD, is the study's corresponding author.

Pairing cancer genomics with cognitive computing highlights potential therapeutic options - Read More…

New simple test could help cystic fibrosis patients find best treatment

New simple test could help cystic fibrosis patients find best treatment

In a significant step toward personalized medicine for cystic fibrosis, a minimally-invasive technique developed in the lab of Martina Gentzsch, PhD, shows promise as a fast, inexpensive indicator to help more patients access new treatments.

New simple test could help cystic fibrosis patients find best treatment - Read More…

The Leukemia & Lymphoma Society awards grant to Savoldo for immunotherapy research

The Leukemia & Lymphoma Society awards grant to Savoldo for immunotherapy research

A grant from The Leukemia & Lymphoma Society will help fund clinical research led by UNC Lineberger's Barbara Savoldo, MD, PhD, into an investigational chimeric antigen receptor (CAR) T-cell treatment for acute lymphoblastic leukemia that would include a built-in "safety switch."

The Leukemia & Lymphoma Society awards grant to Savoldo for immunotherapy research - Read More…